Different Clinicopathological Features of Non-Elderly Sigmoid Volvulus Patients

NCT ID: NCT04360525

Last Updated: 2020-04-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

134 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-01

Study Completion Date

2020-04-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sigmoid volvulus is frequently seen in male patients over 60 years old. In the sigmoid volvulus \<60 age groups, the male/female ratio is close to each other. If sigmoid volvulus develops in \<60 age groups, it is more likely to be another underlying organic pathology.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sigmoid volvulus is frequently seen in male patients over 60 years old. Here, the investigators aimed to investigate the causes of sigmoid volvulus developing in patients under 60 years of age. Patients diagnosed with sigmoid volvulus between 2009 and 2018 were retrospectively screened. The patients were divided into two as under 60 years old and above. The co-morbidity, mortality, morbidity, complications, age and gender data of the patients were analyzed. In the sigmoid volvulus \<60 age groups, the male/female ratio is close to each other. If sigmoid volvulus develops in \<60 age groups, it is more likely to be another underlying organic pathology.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pathology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Elderly patients

Elderly patients (60≤ age) with sigmoid volvulus

Reasons

Intervention Type OTHER

Causes of sigmoid volvulus

Young patients

Young patients (\<60 age) with sigmoid volvulus

Reasons

Intervention Type OTHER

Causes of sigmoid volvulus

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reasons

Causes of sigmoid volvulus

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sigmoid volvulus patients under the age of 60
* Sigmoid volvulus patients at the age of ≥60

Exclusion Criteria

* Lack of data
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Inonu University

OTHER

Sponsor Role collaborator

Dr. Ersin Arslan Education and Training Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ufuk Uylas

Specialist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ufuk uylas, Specialist

Role: PRINCIPAL_INVESTIGATOR

Dr. Ersin Arslan Training and Resource Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr. Ersin Arslan Training and Resource Hospital

Gaziantep, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18042020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.